{"abstract": "After pricing its once-obscure drug, Acthar, in the stratosphere, Questcor gained many fans on Wall Street. But the company has also drawn some doubters.", "web_url": "https://www.nytimes.com/2012/12/30/business/questcor-finds-profit-for-acthar-drug-at-28000-a-vial.html", "snippet": "After pricing its once-obscure drug, Acthar, in the stratosphere, Questcor gained many fans on Wall Street. But the company has also drawn some doubters.", "lead_paragraph": "ANAHEIM, Calif.", "print_section": "BU", "print_page": "1", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2012/12/30/business/30-QUESTCOR-JP1/30-QUESTCOR-JP1-articleLarge.jpg", "height": 406, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2012/12/30/business/30-QUESTCOR-JP1/30-QUESTCOR-JP1-articleLarge.jpg", "xlargewidth": 600, "xlargeheight": 406}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2012/12/30/business/30-QUESTCOR-JP1/30-QUESTCOR-JP1-jumbo.jpg", "height": 692, "width": 1024, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2012/12/30/business/30-QUESTCOR-JP1/30-QUESTCOR-JP1-superJumbo.jpg", "height": 1385, "width": 2048, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2012/12/30/business/30-QUESTCOR-JP1/30-QUESTCOR-JP1-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2012/12/30/business/30-QUESTCOR-JP1/30-QUESTCOR-JP1-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2012/12/30/business/30-QUESTCOR-JP1/30-QUESTCOR-JP1-thumbLarge-v2.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "Questcor Finds Profits, at $28,000 a Vial", "kicker": null, "content_kicker": null, "print_headline": "Finding Profits, At $28,000 a Vial", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "persons", "value": "Bailey, Don M", "rank": 1, "major": "N"}, {"name": "persons", "value": "Kendall, Edward C", "rank": 2, "major": "N"}, {"name": "subject", "value": "ACTH (Adrenocorticotropic Hormone)", "rank": 3, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 4, "major": "N"}, {"name": "organizations", "value": "Questcor Pharmaceuticals Incorporated", "rank": 5, "major": "N"}, {"name": "organizations", "value": "ARMOUR & CO", "rank": 6, "major": "N"}, {"name": "subject", "value": "Health Insurance and Managed Care", "rank": 7, "major": "N"}, {"name": "subject", "value": "Prices (Fares, Fees and Rates)", "rank": 8, "major": "N"}, {"name": "subject", "value": "West Syndrome", "rank": 9, "major": "N"}, {"name": "subject", "value": "Multiple Sclerosis", "rank": 10, "major": "N"}, {"name": "subject", "value": "Acthar (Drug)", "rank": 11, "major": "N"}, {"name": "persons", "value": "Hench, Philip S", "rank": 12, "major": "N"}], "pub_date": "2012-12-29T21:22:06+0000", "document_type": "article", "news_desk": "SundayBusiness", "section_name": "Business Day", "byline": {"original": "By Andrew Pollack", "person": [{"firstname": "Andrew", "middlename": null, "lastname": "Pollack", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/70f73b28-1e6b-5f7c-8333-4f1d5bcb9073", "word_count": 3310, "uri": "nyt://article/70f73b28-1e6b-5f7c-8333-4f1d5bcb9073"}